Exposure to prescribed medication in early life and impacts on gut microbiota and disease development

Huan Huang1,2, Jiayin Jiang1, Xinyu Wang1

  • 1Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China.

Eclinicalmedicine
|February 5, 2024
PubMed

Insights

Early-life medication exposure can disrupt infant gut microbiota development, impacting long-term health. This review explores interventions like probiotics and dietary therapy to mitigate these effects.

Area of Science:

  • Microbiology
  • Developmental Biology
  • Pharmacology

Background:

  • The gut microbiota is critical for infant development, metabolism, and immunity.
  • Early-life pharmaceutical exposure can alter gut microbiota structure and function.
  • These alterations may negatively impact later health outcomes.

Purpose of the Study:

  • To review the establishment of healthy gut microbiota in early life.
  • To summarize common early-life medications and their impact on gut microbiota.
  • To discuss disease pathways linked to medication-induced microbiota changes.

Main Methods:

  • Literature review of early-life gut microbiota establishment.
  • Summary of commonly prescribed medications during pregnancy, childbirth, and infancy.
  • Analysis of disease associations with medication-induced gut microbiota alterations.

Main Results:

  • Common medications like antibiotics and acid suppressants alter gut microbiota composition.
  • Medication-induced dysbiosis is implicated in infections, IBD, metabolic, allergic, and neurodevelopmental disorders.
  • Various therapeutic strategies can potentially restore gut microbiota balance.

Conclusions:

  • Early-life pharmaceutical exposure poses risks to gut microbiota and subsequent health.
  • Interventions including dietary therapy, probiotics, prebiotics, and FMT offer potential preventive strategies.
  • Further research is needed to develop targeted approaches for mitigating medication-induced adverse effects.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
516
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
120
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K